DAWN - DAY ONE BIOPHARMACEUTICALS I
This page shows which of the focused investors we track hold DAWN and how their positions changed, so you can see how much conviction the group has in the stock.
In Q1 2024 it was held by 2 managers with an aggregate reported value of $63.03M, which is 0.01% of the combined portfolio.
As of Q1 2024, 2 tracked institutional managers held DAWN (DAY ONE BIOPHARMACEUTICALS I) with an aggregate reported value of $63.03M — 0.01% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades DAWN — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q1 2024
- Ticker
- DAWN
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Viking Global Investors - Viking Global Investors | 0.16% | - | 2,558,563 | $42.27M |
| 2 | Lee Ainslie - Maverick Capital | 0.40% | New | 1,256,570 | $20.76M |
Loading holder history for DAWN…